news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

Check out the announcement, Xiao E will be the first to report it!

*ST Tongzhou: Wholly-owned subsidiaries and holding companies have temporarily stopped production recently

According to e Company News, *ST Tongzhou (002052) announced on the evening of August 8 that its wholly-owned subsidiary Nanping Tongxin New Energy Technology Co., Ltd., its holding subsidiary Dongguan Tongtai Micro Technology Co., Ltd., and its holding subsidiary Ganzhou Tongzhou New Energy Technology Co., Ltd. (hereinafter collectively referred to as the "temporary suspension company") have recently temporarily suspended production, and will decide whether to resume production at an appropriate time based on market conditions. The temporary suspension company is a manufacturer of some of the company's batteries and PCBA boards, which has continued to lose money in recent years. This temporary suspension is expected to help the company avoid further losses in the future, and it is expected to have an adverse impact on the company's operating income.

Baiyang Pharmaceutical: Plans to invest RMB 59 million to establish Langfang Linkong Baiyang Equity Investment Fund

e Company News, Baiyang Pharmaceutical (301015) announced on the evening of August 8 that the company plans to jointly invest with Beijing Baiyang Zhongxin Kangjian Investment Management Co., Ltd., Hebei Linkong Private Equity Fund Management Co., Ltd., Hebei Linkong Industrial Equity Investment Fund Partnership (Limited Partnership), and Langfang Leading Industry Investment Guidance Fund Co., Ltd. to establish Langfang Linkong Baiyang Equity Investment Fund Partnership (Limited Partnership) (hereinafter referred to as "Investment Fund"). The subscribed capital of the investment fund is 200 million yuan, and the company intends to subscribe 59 million yuan as a limited partner, accounting for 29.5% of the total capital contribution. In addition, the company intends to purchase 10% of the shares of Beijing Mentougou District Baiyang Pharmaceutical Industry Investment Fund held by the controlling shareholder Baiyang Group, corresponding to a subscribed capital contribution of 25 million yuan. Because the capital contribution has not yet been paid, the transaction price is 0 yuan. After the transaction is completed, the company subscribed 74.5 million yuan to the fund, accounting for 29.8% of the total capital contribution.

Jinaobo: Net profit in the first half of the year was 71.7249 million yuan, a year-on-year increase of 54.11%

e Company News, Jinaobao (002917) disclosed its semi-annual report on the evening of August 8. The company achieved operating income of 747 million yuan in the first half of the year, a year-on-year increase of 14.33%; net profit of 71.7249 million yuan, a year-on-year increase of 54.11%; basic earnings per share of 0.21 yuan.

Zhongju High-Tech: Net profit of 350 million yuan in the first half of the year turned losses into profits year-on-year

e Company News: Zhongju High-Tech (600872) released its semi-annual report on the evening of August 8, with operating income of 2.618 billion yuan in the first half of the year, a year-on-year decrease of 1.35%; net profit of 350 million yuan, turning losses into profits year-on-year, with a loss of 1.443 billion yuan in the same period last year; basic earnings per share of 0.447 yuan.

Yanggu Huatai: Plans to repurchase shares for cancellation with a total amount of RMB 50 million to RMB 100 million

e Company News, Yanggu Huatai (300121) announced on the evening of August 8 that it plans to repurchase the company's shares for 50 million to 100 million yuan to cancel and reduce registered capital, and the repurchase price shall not exceed 11.5 yuan per share (inclusive). Yanggu Huatai also disclosed its semi-annual report, with a net profit of 139 million yuan in the first half of the year, a year-on-year decrease of 33.71%. The company plans to pay a cash dividend of 0.5 yuan (including tax) for every 10 shares.

Northeast Pharmaceutical: Dingcheng Peptide Source Company has no substantial income at present

According to e Company News, Northeast Pharmaceutical (000597) issued an unusual announcement on the evening of August 8, stating that the company's acquisition of 70% of the equity of Beijing Dingcheng Peptide Source Biotechnology Co., Ltd. is still uncertain. As of now, Dingcheng Peptide Source's product pipeline is in the preclinical research and development and clinical application stage. During this stage, the company has no substantial income and is in an operating loss state, and its net assets are also negative.

Cambridge Technology: Net profit in the first half of the year decreased by 48.69% year-on-year; plans to pay 0.3 yuan per share

e Company News, Cambridge Technology (603083) disclosed its semi-annual report on the evening of August 8, achieving operating income of 1.762 billion yuan in the first half of the year, a year-on-year increase of 1.31%; net profit of 80.0039 million yuan, a year-on-year decrease of 48.69%. The company plans to pay a cash dividend of 0.3 yuan (including tax) for every 10 shares. In addition, Shanghai Kangyiqiao Investment Consulting Partnership (Limited Partnership), a shareholder holding 0.9407% of the company's shares, plans to reduce its holdings of no more than 0.9407% of the company's shares.

Shaanxi Black Cat: Actual controller plans to increase company shares by 100 million yuan

e Company News, Shaanxi Black Cat (601015) announced on the evening of August 8 that the company's actual controller Li Baoping plans to increase his holdings of the company's shares within 6 months, with the increase amount being 100 million yuan.

ST Dongshi: The actual controller of the company, Xu Xiong, received a notice of filing by the China Securities Regulatory Commission

e Company News, ST Dongshi (603377) announced on the evening of August 8 that the actual controller of the company, Xu Xiong, received the "Notice of Filing" issued by the China Securities Regulatory Commission on August 7. Because of his suspected illegal and irregular information disclosure, the China Securities Regulatory Commission decided to file a case against Xu Xiong. In view of the fact that Xu Xiong was approved for arrest by the First Branch of the Shanghai Procuratorate in 2023 for suspected crimes of manipulating the securities market, Xu Xiong has entrusted the company's chairman Xu Jinsong to handle the receipt and disclosure of his "Notice of Filing" on his behalf. So far, the company's business activities are proceeding normally.

Hongbo New Materials: Xinyu Baolong plans to reduce its holdings of no more than 3% of the company's shares

e Company News, Hongbo New Materials (605366) announced on the evening of August 8 that the company's shareholder holding 7.04% of the shares, Xinyu Baolong Enterprise Management Center (Limited Partnership) (referred to as "Xinyu Baolong"), intends to reduce its holdings of the company's shares by no more than 18.265 million shares through centralized bidding and/or block trading within 3 months after 15 trading days, with a total of no more than 3% of the company's total share capital.

Haimuxing: Won the bid for a project worth about 1.25 billion yuan from a leading overseas automaker

e Company News, Haimuxing (688559) announced on the evening of August 8 that the company received a notice of winning the bid from a leading overseas automobile company. The winning bid amount is equivalent to RMB 1.25 billion, and the winning project is power battery laser and automation-related equipment.

Ankai Bus: Cumulative sales of buses in the first seven months reached 3,164 units, a year-on-year increase of 62.09%

e Company News: Ankai Bus (000868) announced on the evening of August 8 that its bus sales in July were 450 units; the cumulative sales this year were 3,164 units, a year-on-year increase of 62.09%.

Linglong Tire: Controlling shareholder plans to increase its stake in the company by RMB 150 million to RMB 200 million

e Company News: Linglong Tire (601966) announced on the evening of August 8 that the controlling shareholder Linglong Group plans to increase its holdings of the company's shares by RMB 150 million to RMB 200 million, with no price range set for this increase. At the same time, the company plans to change the purpose of the repurchased shares and cancel the repurchased shares in the repurchase special securities account. The planned cancellation amount is 10.02 million shares, accounting for 0.68% of the company's current total share capital. In addition, the company plans to carry out an overseas (Serbia) investment expansion project with a total investment of US$645 million (RMB 4.621 billion).

Editor: Peng Bo

Proofread by: Wang Chaoquan